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Chapter 1. Environmental Enteric
Dysfunction (EED) Background
1.1 EED History and Overview
For many years it has been known that the digestive system, and in particular the small
bowel, of people who reside in poor regions do not function well. The first English language
description of this disorder was written by William Hillary in the mid-1700s. His case series of
malabsorption in European expatriates in Barbados [2] (reviewed by Booth [3]) also reported
glossitis (most likely caused by concomitant folate deficiency) and diarrhea. Over a century
later, Patrick Manson re-described this disorder, again focusing on expatriates in the Dutch
West Indies, and used the term tropical “Sprouw,” from a Dutch word describing what was
almost certainly celiac disease (gluten-sensitive enteropathy) in Europe [4]. The onset of this
malady in previously healthy Europeans residing in the tropics, and reports of epidemic
malabsorption in Allied troops in Southern Asia during the Second World War [5, 6], gave rise to
the concept of gut lesions caused by “environmental” factors. Therefore, this enteropathy was
modeled as an acquired, likely infectious, problem [7]. This acquired/environmental concept was
reinforced by secular variances in the incidence of tropical malabsorption syndromes,
alternately referred to as tropical enteropathy (TE), in areas previously endemic for this disorder
[8, 9].
The early descriptions of tropical enteropathy did not define the true extent of the
problem. Most notably, these initial reports focused on adults. The realization that children were
affected by what was probably the same disorder was delayed. Second, while various causes of
this intestinal dysfunction have been postulated, the definitive cause or causes remain(s)
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elusive. Indeed, interest and investigation into the problem itself waxes and wanes with
discoveries of new enteric pathogens. This has implications for our systematic review of the
problem. For example, giardiasis would be a lead candidate as a cause of tropical enteropathy
in view of the chronicity of the illnesses it can cause, and the ability of Giardia to injure the
mucosa of the small bowel. However, Giardia lamblia was not widely accepted as a human
pathogen until the 1970s. Hence, prior investigations would have discounted this agent as being
a cause of enteropathy. Third, there have been regional differences in the reported incidence of
tropical enteropathy. Early communications suggested that individuals in Africa were seemingly
less affected than were individuals in other areas, and that many cases of adult malabsorption
were attributed to biliary and pancreatic disorders [10]. However, more recent reports suggest
that Africans are, indeed, susceptible to tropical enteropathy [11-15]. Also, diagnosis in early
studies was made by varying methodologies, including those based on response to empiric
treatments (antibiotics, antiparasitics, micronutrients) and repatriation to countries in which
tropical enteropathy is not endemic; it is often unclear from which intervention(s) responders
benefitted. Finally, enteric dysfunction in resource-poor settings has often eluded, and continues
to elude, useful definition. Instead, we are forced to rely on histopathologic findings from the
small bowel, and these findings are variably specific. These abnormalities include villous
blunting, increased crypt:villous ratios, and presence of intraepithelial lymphocytes (IEL).
However, the reliance on biopsies skews disease detection and data acquisition towards adults
who more frequently undergo invasive testing [16]. These definitional issues continue to hinder
advancement in the field, and to impose challenges in identifying useful biomarkers.
The nomenclature used to describe the entity of interest has shifted in response to
ongoing efforts to better understand and describe the disease. As early as 1984, the term
“environmental enteropathy” was used synonymously with “tropical enteropathy” [17], although
not commonly until 2004 [18]. Most recently, "environmental enteric dysfunction" (EED) has
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been suggested as nomenclature for the entity of interest [16]. We adopt this term in this book
as it provides specificity with regards to the origin of intestinal dysfunction (i.e., environmental
opposed to genetic or other factors) and focuses on functional alterations of consequence [19].
The term EED refers to functional shortcomings of the gut with and/or without histological
correlates, and obviates the need to rely on the histology inferred by the term “enteropathy" 1.
We acknowledge that EED might differ in disease burden, etiology, and effects in children and
adults in different regions. However, independent of case definition or underlying criteria,
suboptimal intestinal function in children in resource-poor environments is common, and it is
important to determine its true incidence, spectrum of host injury, mechanisms of
pathophysiology, diagnostic ascertainment, clinical consequences, and mitigation via
interventions whether prevention or treatment. Therefore, it is now time to measure the extent of
this dysfunction and its consequences. To do so, we need to consider the technology that will
be required to investigate the problem.

1.2 An Old Problem Requiring New Knowledge
There is a compelling need for research on enteric dysfunction in children in resourcepoor environments, but scientific advancement in the field has been, in fact, quite modest. The
Web of Science (formerly ISI Web of Knowledge) demonstrates a paucity of publications related
to EED (Figure 1).
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Strictly speaking, the “-pathy” suffix is from the Greek word for disease or suffering, but in many
connotations refers to histopathologically defined disorders.
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Figure 1. List of plausibly relevant literature from 1980 to 2010.
A search of Thomson Reuters Web of Science™ ALL Databases Collection 1 on 27 August
2014, spanning 1980-2010 and using any of the following search terms: "tropical enteropathy",
"environmental enteropathy", "tropical sprue", "environmental enteric dysfunction", "tropical
malabsorption syndrome", or "tropical malabsorption." Topic was used for the query, with the
phrase enclosed in quotation marks. Search filters for language or document type were not
applied.
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The lack of progress on EED contrasts with recent dramatic advances in mortality
reduction caused by acute enteric infections. The annual number of deaths attributed to
diarrhea among children under five years of age fell from an estimated 4.6 million in 1980 [20] to
about 700,000 in 2011 [21]. Most of the mortality reduction in the latter two decades of the past
century was likely a result of refinements in, and/or increased use of, oral rehydration
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Searches were conducted using the Thomson Reuters Web of Science™ ALL Databases Collection and
reflect only the data as indexed by the database. Publication data may be incomplete. The Thomson
Reuters Web of Science™ ALL Databases Collection consisted of Inspec® (1898-present), MEDLINE®
(1950-present), SciELO Citation Index (1997-present), Science Citation Index Expanded (1970-present),
Social Sciences Citation Index (1970-present) and Art & Humanities Citation Index (1975-present).
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therapy(ORT) [22, 23]. Globally, current ORT coverage rates are moderate and have stabilized
over the past decade [24]; more recent reductions in diarrhea-related mortality likely stem from
general improvements in socioeconomic development, nutrition, and water/sanitation
infrastructure [25]. Coverage rates for access to improved water sources, particularly in urban
settings, are on track to meet international development goals [26]. However, access to
adequate quantities of water, water of sufficient quality for drinking, and improved sanitation
facilities are limited and only slowly improving [26-28]; the same lack of progress applies to
hand hygiene prevalences [29]. Improved water sources, sanitation, and hygiene can avert 58%
of childhood diarrhea-related deaths in low- and middle-income countries [27]. A 34% reduction
in risk of diarrheal disease has been demonstrated with interventions to improve water quality,
and a 28% reduction in diarrheal disease has been observed with improvements in sanitation,
particularly sewer interventions [30]. Promotion of hand hygiene with soap is estimated to
contribute to a 23% reduction in diarrheal disease risk [29].
Treatment with zinc can reduce the duration and severity of acute episodes of diarrhea
and reduce the risk of future episodes [31-33]. Since 2004, zinc has been a recommended
therapeutic for children suffering from diarrheal episodes in resource-limited settings. Safe and
effective rotavirus vaccines are now available and recommended for widespread use [34-36].
Coverage rates for these relatively “new” interventions are low, but their implementation is
accelerating. Major advances might also be on the horizon in the form of effective cholera,
typhoid, Shigella, and enterotoxigenic Escherichia coli (ETEC) vaccines [37-39].
Despite reductions in mortality risk associated with acute diarrhea, enteric infections
remain prevalent. Over 1.7 billion episodes of diarrhea occur among children under five years of
age each year [21] and incidence rates have not changed markedly in the past several decades
[40]. Repeated episodes of infection in the developing gut are probably deleterious [41].
Expanded implementation of prevention and treatment measures could further diminish diarrhea
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mortality and could additionally reduce morbidity and disease burden. However, these advances
against acute enteric infections now raise the relative importance of chronic intestinal
dysfunction as a hindrance to optimal childhood health [42].
However, this problem is much more complex: emphasis on acute enteric infection fails
to address the consequences of recurrent, persistent, and chronic diarrhea, as well as the longterm consequences of diarrhea on stunting and on disability-adjusted life years. Also, a new
variety of agents, in particular enteroaggregative Escherichia coli, and Cryptosporidia spp.,
which each require special technologies to identify, have recently and repeatedly been
associated with persistent diarrhea and stunting. Additionally, several epidemiologic studies
suggested that the frequency of episodes of acute diarrhea impairs long-term health in
populations outside Brazil [18, 43, 44]. In view of the successes of oral rehydration and the
rotavirus vaccine, it was reasonable to assume that the problem of enteric infections in children
would be solved. Moreover, simple infrastructural management strategies, particularly the
provision of appropriate village waste containment facilities [45] were determined to be
important protective measures against chronic diarrhea. We now recognize that enteric
inflammation is a determinant of stunting and long-term gastrointestinal dysfunction, even
independent of the presence of the more easily enumerable episodes of diarrhea [45].
The renewed interest in EED is aptly timed for many different reasons. As noted above,
we are in an era in which we know how to treat and prevent acute diarrhea. Therefore, chronic
intestinal injury and inflammation now pose larger proportional threats to population and
childhood well-being. Also, translational research has created new proteomic, metabolomic, and
genomic technology with which to study human pathophysiology. The value of re-examining and
expanding diagnostic capabilities is two-fold. First, such efforts will shed light on incidence rates
within communities and assess factors associated with differences in disease rates in various
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populations. Second, such tools might accurately identify children at risk of developing EED,
who have EED (at its various clinical stages), and as a way to monitor treatment for EED.
We recognize that other priorities compete with EED for resources in the field of child
health. First, there is the imperative to continue to reduce mortality from acute diarrhea. Indeed,
the Child Health and Nutrition Research Initiative of the Global Forum for Health Research
methodology de-emphasized research on chronic enteric conditions in favor of implementing
available strategies to continue to reduce acute childhood diarrhea mortality [46, 47]. That
analysis was weighted towards interventions that could be implemented by 2015 to meet
Millennium Development Goals. EED intervention studies require longer investigation periods
than do disorders with known etiologies and outcomes that are apparent in the short term. For
example, the pathophysiology of EED is not well understood, technologies sufficient to assess
the process in individual hosts or within populations are not broadly available, and interventions
to mitigate consequences of clinical importance are not yet established. Work to understand and
control EED should be viewed as complementing, rather than competing with, continued efforts
to reduce the burden of acute enteric illnesses. It was with this concept in mind that we
embarked on our review of the EED literature, with a goal of providing a platform on which
future EED efforts, especially those related to biomarkers and diagnostics, could be built.

1.3 Pathophysiologic Processes and Consequences
of EED
The gut is an organ that is central to health and development. Healthy intestinal
functioning optimizes childhood physical and intellectual well-being and development, and
enables children to achieve adult stature. Several lines of evidence indicate that suboptimal
functioning of the human gut, manifesting as EED, leads to poor health for children in resourcepoor settings. First, investigators in Fortaleza, Brazil have demonstrated that episodes of
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recurrent or persistent diarrhea are major determinants of childhood growth impairment [48],
and subsequent reduced growth and intellectual capacity at school entrance [49, 50]. These
investigations were seminal because they provided a new metric for calculating the burden of
enteric-related disease other than counting deaths or numbers of episodes of loose stools. This
is also important because stunting can be associated with subclinical intestinal inflammation [15,
51].
Multiple aspects of intestinal pathophysiology contribute to poor health, growth and
development (Figure 2) and physiologic derangements in these processes are deleterious
(Figure 3). First, injured intestinal mucosa absorbs nutrients poorly [52] and represents one
potential EED-mediated growth-failure pathway [15, 53]. Chronic intestinal inflammation is very
common in the tropics [54] and can damage intestinal epithelial integrity and disrupt tight
junctions, resulting in intestinal permeability defects. Multiple studies demonstrate increased
intestinal porosity in children in the tropics [15, 44, 55-58]. Increased intestinal permeability can,
in turn, lead to translocation or the nonphysiologic uptake of intestinal luminal contents,
including microbes and microbial products, into the bloodstream [59]. Microbial translocation
can, in turn, mediate systemic inflammation as can chronic intestinal inflammation. Stunting is
often associated with subclinical intestinal inflammation [15, 51]. Systemic inflammation can
penalize growth by interrupting bone growth potential, release of growth hormone binding
proteins at the level of the liver [60], suppressing appetite, and increasing metabolic
requirements [61]. Such mechanistic attribution remains hypothetical at this juncture.
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Figure 2. The vicious cycle of intestinal dysfunction, infectious disease susceptibility,
poor growth, and development.
NCDs= non-communicable diseases. WaSH=water, sanitation and hygiene. EED=
environmental enteric dysfunction.

Adapted from Denno DM [62], Guerrant RL, et al. [63] and Mata L [64].
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Figure 3. EED-related pathophysiological processes result in stunting and/or growth
shortfall.
Growth can be affected by disturbances in a variety of intestinal and other physiologic
processes resulting from EED. GH=growth hormone.

The first several years of childhood represent a critical period that influences life-long
nutritional and health status and human potential [65]. Stunting is an especially important cause
of adverse consequences in resource-poor regions, and stunting that occurs in the first two
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years of life is particularly consequential [48, 66-72]. Childhood stunting is associated with
cognitive impairment, poor school performance, and reduced adult capacity [73-76]. Clinical
complications of childhood stunting also include predisposition to obesity and diabetes and
other chronic diseases in later adulthood—a double burden increasingly afflicting populations in
resource-limited settings [65]. Moreover, undernutrition contributes to over one-third of
childhood deaths [77].
Poor nutrition among girls can have a particularly profound effect on future reproductive
and fetal/neonatal health. For example, maternal stunting can be a risk factor for obstructed
labor, stillbirth, and neonatal mortality [78]. Furthermore, maternal anthropometry also
influences future generational growth, morbidity and mortality [79].
Dysfunctional guts can hinder the efficacy of oral vaccinations and absorption of
medications. This may pose a threat to oral enteric vaccine strategies and absorption of
medications for chronic infections such as tuberculosis and HIV/AIDS [80]. Indeed, failure of oral
polio vaccine to induce protective immunity in children at risk is a major challenge to disease
eradication [81].
Increasing dietary nutrient provision does not necessarily or completely resolve growth
failure in resource-poor settings [82]. Gut function is an important antecedent to healthy human
growth and development. Strategies are needed to ascertain gut inflammation, increased
permeability, and decreased absorption. Strategies are also needed to measure and address
the persistence, progression, and resolution of these types of dysfunction. Chronic intestinal
inflammation and inability to absorb nutrients may be the most actionable manifestations of
enteric dysfunction in children. Intervention studies to mitigate EED will require appropriate,
robust and reproducible methods to identify children with intestinal dysfunction, ideally before
penalties to growth and development accrue.
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A coordinated effort to control EED in children in resource-poor regions could markedly
reduce childhood undernutrition, poor development, and mortality. In the past decade, we have
seen an explosion in our understanding and abilities to diagnose an analogous disorder, i.e.,
celiac disease, which has histopathologic similarities to EED. We have learned the genetic and
environmental, i.e., dietary, risk factors for celiac disease, and also determined that this disorder
is not confined to individuals of northern European ancestry, as previously thought.
Furthermore, the diagnosis and management of celiac disease, including partial mitigation of
growth consequences, has advanced, at least in high-income countries. Similar data are
emerging regarding the more challenging disorders of inflammatory bowel disease, i.e., Crohn’s
disease and ulcerative colitis [83]. We can apply lessons learned from these chronic intestinal
inflammatory states to the study of EED.
There is reason to be optimistic about renewed research and development relevant to
EED. Emerging technologies can interrogate human processes and microbial populations to an
extent not predicted even a few years ago. These technologies can shed new light on EED, an
entity that has traditionally required tissue for diagnosis.

1.4 The Role of Biomarkers and Diagnostics in EED
Much as pioneering studies on mechanisms of intestinal secretion in cholera [84] formed
the basis for giving oral rehydration solution to children with diarrhea worldwide, it is critical to
identify the mechanisms underlying intestinal dysfunction in children in resource-poor areas.
Beyond searches for specific etiologic pathogens or nutritional deficiencies, biomarkers and
diagnostics will need to be broadly considered in favor of pursuing a better understanding of
EED as a disorder. “Discovery” efforts will be needed to generate sufficient information to move
forward.
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Broad-based research is urgently needed to invigorate the field. For example, multidimensional assessments of individuals and populations will be necessary to measure intestinal
dysfunction, and identify factors that precipitate and perpetuate EED. We believe that the utility
of biomarkers in EED needs to extend beyond the concept of diagnostics. Diagnostics, as most
commonly used to assess the human gut, usually seek specific pathogens, or belong to a
limited panel of tests of gut inflammation and/or absorptive function. It is likely that rigorous and
systematic analyses of EED require a better understanding of the microbial population in the gut
and detailed assessments of intestinal inflammation, absorption, permeability, translocation, and
subsequent systemic inflammatory cascade as well as the precipitants and consequences of
EED, such as nutrient deficiencies. As such, we sought to systematically search, review and
portray the existing diagnostics/biomarkers literature related to EED as a basis of knowledge to
leverage further investigation.

1.5 Scientific Basis for this Review
In view of increasing understanding of the role of gut health and function in promoting
overall health and development in childhood and beyond, it is logical to catalyze efforts to
accurately identify and predict children with EED and to refine the sensitivity and specificity of
promising biomarkers. While a single marker with optimal operating characteristics would be a
welcome tool, it is unlikely that a single test can be used worldwide to detect and predict EED
with the necessary precision. A panel of tests, perhaps in conjunction with clinical
characteristics, may be necessary, akin to the Jones criteria used to diagnose acute rheumatic
fever.
Currently, there is no consensus on the best way to measure intestinal function either
invasively or noninvasively. Additionally, there is no evidence that the entities of interest, i.e.,
intestinal inflammation and/or poor function associated with stunting, are caused by a single
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etiology or that a common pathogenesis underlies all cases. Also, we do not know if intestinal
inflammation precedes growth failure, if the disorder might actually begin in utero, or if any
therapies can reliably and uniformly restore linear growth. Nonetheless, there is now consensus
that stunted children are not only at risk for unhealthy consequences during childhood, they are
more likely than their non-stunted peers to develop chronic disorders that extend into adulthood,
including obesity, type II diabetes, and hypertension [85, 86]. Clearly there is a need to reassess
whether existing markers of intestinal dysfunction can better define the disorder of interest, and
anticipate its development in children. We therefore attempted to first identify the current state of
the knowledge, then delineate gaps in that knowledge, and, finally, sought to determine which
tests might have the most utility.
Table 1. Spectrum of etiologies, outcomes, and biomarkers/diagnostics in EED.
These lists of causes, results, and techniques to identify EED were used to define manuscripts
of potential interest in the list generated by the search terms.
Potential drivers (causes) of EED

Pathogens, food insecurity, immune activation, specific
nutrient deficiencies, environmental hygiene

Potential consequences of EED

Recurrent diarrhea, persistent diarrhea, intestinal
inflammation with and without diarrhea, stunting

Possible biomarkers/diagnostics of
EED

Biopsies, sugar clearance tests (measuring absorption
and permeability of the gut), breath hydrogen tests,
nutrient challenge tests, fecal analyses for leakage or
non-absorption, serologic analyses for inflammation or
evidence of gut permeability
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